NeyroblastGX LLC develops theranostic (therapeutics and diagnostics) products for neurodegenerative and infectious diseases like Alzheimers disease and COVID-19. In addition to theranostic products, the company has developed a platform to provide custom-made human organdies and genetically engineered cells for screening drug, toxicity, and disease pathology. The firm's Alzheimer's blood-based biomarker diagnostic is a non-invasive method for detecting Alzheimer's disease that tests a small amount of blood and provides a rapid, highly sensitive, and precise diagnosis of AD biomarker proteins. Two COVID-19 solutions include a theranostic solution that utilizes dendritic cells (DCs) as antigens as well as an oral supplement to protect daily immunity and prevent secondary infection after recovery.
